Cited by 222Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsCancer-related Molecular Pathways

Two-Step Senescence-Focused Cancer Therapies

Open access
Sieben, Cynthia J., Sturmlechner, Ines, van de Sluis, Bart, van Deursen, Jan M.·2018·Trends in Cell Biology

Abstract

Damaged cells at risk of neoplastic transformation can be neutralized by apoptosis or engagement of the senescence program, which induces permanent cell-cycle arrest and a bioactive secretome that is implicated in tumor immunosurveillance. While from an evolutionary perspective senescence is beneficial in that it protects against malignancies, the accumulation of senescent cells in tissues and organs with aging and at sites of various pathologies is largely detrimental. Because induction of senescence in cancer cells is emerging as a therapeutic concept, it will be important to consider these detrimental effects, including tumor-promoting properties that may drive the formation of secondary tumors or cancer relapse. In this review we discuss the complex relationship between senescence and cancer, and highlight important considerations for therapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tcb.2018.04.006

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Combining senogenic and senolytic compounds could have a synergistic antitumor effect that could be effective in cancer treatment.

    “In our view, combining senogenic and senolytic compounds could have a synergistic antitumor effect that could prove very effective in cancer treatment47.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [54]Witkiewicz AK 2011 Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment Am J Pathol 179 1171 1178 21756866 PMC3157259
  2. [73]Lancet JE 2000 Acute myelogenous leukemia and aging. Clinical interactions Hematol Oncol Clin North Am 14 251 267 10680081

Cited by

Sorted by citations

Authors
Sieben, C. J., Sturmlechner, I., van de Sluis, B., & van Deursen, J. M.
Affiliations
Mayo Clinic (US)
Venue
Trends in Cell Biology
Publisher
Elsevier BV
Published
2018-09
Volume
28
Issue
9
Pages
723-737
ISSN
0962-8924 (ISSN-L)
OpenAlex
W2804523989
Cited by
222
References
127
Citations by year
2026: 18 · 2025: 20 · 2024: 36 · 2023: 31 · 2022: 27 · 2021: 27 · 2020: 32 · 2019: 26 · 2018: 5
FWCI
2.99
Type
journal article
Language
en
Open access
Locations
  • Trends in Cell Biology (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Funders
  • Mayo Clinic
  • National Cancer Institute (R01CA166347, R01CA096985)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
cellular senescence, senescence-associated secretory phenotype, senescence therapy, cancer therapy, tumor surveillance, senolytics, aging, tumor recurrence, apoptosis, cell cycle arrest
MeSH terms
Aging, Animals, Antineoplastic Agents, Humans, Immune System, Models, Biological, Neoplasms, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review